Correlation between methotrexate-induced intestinal damage and decrease in polyamine content

Area of Science:

• Gastroenterology
• Pharmacology
• Biochemistry

Background:

• Methotrexate (MTX) is a chemotherapy agent that can cause significant damage to the small intestine.
• Understanding the biochemical mechanisms underlying MTX-induced intestinal damage is crucial for developing protective strategies.

Purpose of the Study:

• To evaluate the protective effect of OP-1206, a synthetic prostaglandin E(1) analog, against MTX-induced biochemical damage in the rat jejunal mucosa.
• To investigate the role of polyamines in MTX-induced intestinal injury and OP-1206's potential modulatory action.

Main Methods:

• Rats were administered MTX (15 mg/kg) daily for 5 days to induce small intestinal damage.
• OP-1206 (0.5 microg/kg) was co-administered twice daily for 5 days.
• Biochemical components (DNA, RNA, proteins, polyamines) and DNA synthesis (3H-thymidine incorporation) in jejunal mucosa were assessed on day 6.

Main Results:

• MTX treatment significantly decreased jejunal mucosa DNA, RNA, protein, and polyamine content.
• MTX administration also reduced the incorporation of 3H-thymidine into DNA.
• Coadministration of OP-1206 with MTX prevented these biochemical decreases and preserved DNA synthesis.

Conclusions:

• OP-1206 demonstrates a protective effect against the biochemical damage induced by MTX in the rat small intestine.
• This protection is likely mediated by a trophic action on intestinal villi, preserving key cellular components and DNA synthesis.
• Polyamines may play a significant role in modulating intestinal mucosa integrity during MTX treatment.